Blog
CordenPharma’s €900m Investment to Dominate Peptide Market
📢 CordenPharma invests €900m in peptide platform expansion, aiming to become a market leader and reach €1bn in sales by 2028. 🔬💊💪
Catalym Raises $150m for Cancer Breakthrough
💰 German cancer specialist Catalym GmbH raises $150m to fund proof-of-concept studies 🔬💉🧪💼 Exciting progress in solid tumor treatment!
Revolutionizing Bioprocessing: AI Integration Demands Cultural Shift
📰 Integrating AI into bioprocessing requires a cultural change within companies, says Varsha Daswani from Lumilytics. 🔄 Bioprocessing specialists and data science experts need to communicate and find ways to integrate AI into workflows. ⚙ Data preparation, standard formatting, and clear definitions of data usage are crucial for success. 🧪 Lumilytics helps with end-to-end process optimization and smaller-scale projects such as automating data analysis. 📊 Understanding the capabilities and use cases of AI technology is essential for successful implementation.
French Company’s Breakthrough Treatment Halts Hearing Loss
📢 Exciting news! Sensorion SA has achieved positive results in their Phase II trial for SENS-401, a treatment for hearing loss. 🦻🔬👂
Rentschler Biopharma Doubles Production Capacity Making History
🏢 Rentschler Biopharma doubles cGMP capacity with new US production line, aiming to expand in complex biologics market. 🌍📈💰
Massachusetts Welcomes Fully Operational Biopharma Powerhouse
📢 Rentschler Biopharma's new production line in Massachusetts is now fully operational. 🏭 The multi-product facility doubles the company's global capacity and focuses on the commercial production of complex molecules. 🔬 The production line includes four new 2,000L single-use bioreactors and adds 22,000 square feet of cleanroom space. 🇺🇸 CEO Benedikt von Braunmühl highlights the company's strong capabilities in the US. 🚀 Rentschler Biopharma contributed to nearly 25 of FDA-approved biopharmaceuticals in 2023.
Revolutionary Atlas System Transforms Bioprocessing Analysis
🔍 Nirrin Technologies launches Atlas system for at-line analysis in bioprocessing applications, revolutionizing analytical workflow. 🌐💡🔬📈🌟
German Biotech Startup Raises €63m for Groundbreaking Autoimmune Research
🎉 German biotech SciRhom GmbH secures €63m in Series A funding to advance clinical proof of concept in autoimmune disorders. 💪🔬🌍
Boosting Biosimilar Adoption in Low-Income Countries: Revolutionary Process Optimization Techniques Unveiled!
🔍 A biosimilar manufacturer is using innovative techniques to cut costs and improve yields, boosting adoption in lower-income countries. Join them at the Bioprocessing Summit in Boston! 🌍💉🔬
Revolutionizing Bioprocessing: Faster Easier Cost-efficient Analysis
🔍 Bioprocessing analytics tools are complex, but developers aim to make them accessible for bioprocess scientists. 🧪💰 908 Devices' Rebel device cuts analysis time from weeks to 12 minutes. ⏱️💉 Industry collaboration and regulatory support drive biomanufacturing innovation.
